| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |